[1]
A. Pote, “Clinical pharmacokinetics and pharmacodynamics of vildagliptin 50 mg sustained release tablet formulation in healthy Indian males after single and multiple-dose”, Int J Res Med Sci, vol. 9, no. 2, pp. 510–517, Jan. 2021.